Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | GAA | P10253 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | G6PD | P11413 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1701096 | 0.91 | TSHR (0.46) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL22401850 | 0.83 | CYP3A4 (0.48) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL31634593 | 0.82 | CYP3A4 (0.52) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL5884188 | 0.82 | CYP3A4 (0.52) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL28575331 | 0.80 | CYP3A4 (0.50) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL3046974 | 0.79 | CYP3A4 (0.55) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL1199708 | 0.79 | CYP3A4 (0.63) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL2955553 | 0.79 | CYP3A4 (0.55) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL31387618 | 0.79 | CYP3A4 (0.63) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR | |
| SCHEMBL68996 | 0.79 | ALOX15 (0.43) | ALDH1A1ALOX15HSD17B10CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111952549-B | Carbon-coated lithium battery negative electrode material with yolk-eggshell structure and preparation method thereof | 宝山钢铁股份有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-111952549-A | Carbon-coated lithium battery negative electrode material with yolk-eggshell structure and preparation method thereof | 宝山钢铁股份有限公司 | 2020-11-17 | — | — | CN | claimed |
| US-20260008760-A1 | DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED | 2026-01-08 | — | — | US | disclosed |
| CN-119948034-A | Novel peptide-based nitrile compound and application thereof | 上海壹迪生物技术有限公司 | 2025-05-06 | — | — | CN | disclosed |
| EP-4539840-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119730846-A | Kinase modulators and methods of use thereof | 神经元23公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2023244788-A9 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. (US) | 2024-09-12 | — | — | WO | disclosed |
| CN-117964637-A | Novel peptide-based nitrile compound and application thereof | 上海壹迪生物技术有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024088307-A1 | NOVEL PEPTIDYL NITRILE COMPOUND AND USE THEREOF | 上海壹迪生物技术有限公司 | 2024-05-02 | — | — | WO | disclosed |
| US-20240025906-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | SUNDANCE BIOSCIENCES, INC. | 2024-01-25 | — | — | US | disclosed |
| WO-2023244788-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2014203217-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS AS CRAC MODULATORS | LUPIN LIMITED (IN) | 2014-12-24 | — | — | WO | disclosed |
| US-20140206663-A1 | TRIAZINONE COMPOUNDS | WUXI APPTECH (SHANGHAI) CO., LTD. (CN) | 2014-07-24 | — | — | US | disclosed |
| US-8093238-B2 | Fused thiazole derivatives as kinase inhibitors | UCB PHARMA S.A. (BE) | 2012-01-10 | — | — | US | disclosed |
| US-20100069361-A1 | Fused Thiazole Derivatives as Kinase Inhibitors | UCB PHARMA S.A. (BE) | 2010-03-18 | — | — | US | disclosed |
| EP-2076512-A1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB Pharma S.A. (BE) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008044022-A1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA S.A. (BE) | 2008-04-17 | — | — | WO | disclosed |
| EP-0141377-B1 | METAL COMPLEXES | HODOGAYA CHEMICAL CO., LTD. (JP) | 1990-05-02 | — | — | EP | disclosed |
| US-4563409-A | ELECTROGRAPHY | HOGOHAYA CHEMICAL CO., LTD. (JP) | 1986-01-07 | — | — | US | disclosed |
| EP-0141377-A2 | Metal complexes | HODOGAYA CHEMICAL CO., LTD. (JP) | 1985-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140206663-A1 | TRIAZINONE COMPOUNDS | THPO, IL5, CYP11B2 | ALDH1A1 462/4885ALOX15 1205/4885HSD17B10 1140/4885 |
| US-20100069361-A1 | Fused Thiazole Derivatives as Kinase Inhibitors | JAK1, MTOR, MOK | ALDH1A1 1714/4885ALOX15 1219/4885HSD17B10 2961/4885 |
| US-20260008760-A1 | DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | DPP9, DPP7, DPP4 | ALDH1A1 245/4885ALOX15 2760/4885HSD17B10 172/4885 |
| US-20240025906-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | TYK2, JAK1, JAK3 | ALDH1A1 4807/4885ALOX15 3189/4885HSD17B10 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.